Baader Bank Aktiengesellschaft Dexcom Inc Transaction History

Baader Bank Aktiengesellschaft

  • $1.63 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024
BUY
$110.31 - $140.45 $191,167 - $243,399
1,733 Added 35.22%
6,653 $754,000
Q1 2024

May 03, 2024
BUY
$114.22 - $140.1 $561,962 - $689,292
4,920 New
4,920 $682,000
Q2 2023

Aug 11, 2023
BUY
$112.47 - $130.98 $226,289 - $263,531
2,012 New
2,012 $258,000

Others Institutions Holding DXCM

# of Institutions
1,014
Shares Held
351M
Call Options Held
5.51M
Put Options Held
5.6M
View Full List

About DEXCOM INC

DXCM Quotes by TradingView
  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Baader Bank Aktiengesellschaft Portfolio

Follow Baader Bank Aktiengesellschaft and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baader Bank Aktiengesellschaft, based on Form 13F filings with the SEC.

News

Stay updated on Baader Bank Aktiengesellschaft with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email